Liver tumor model with implanted rhabdomyosarcoma in rats: MR imaging, microangiography, and histopathologic analysis

Radiology

Volumn 239, Issue 2, 2006, Pages 554-562

  Chen, Feng ^a,b   Sun, Xihe ^a,c   De Keyzer, Frederik ^a   Yu, Jie ^a   Peeters, Ronald ^a   Coudyzer, Walter ^a   Vandecaveye, Vincent ^a   Landuyt, Willy ^a   Bosmans, Hilde ^a   Van Hecke, Paul ^a   Marchal, Guy ^a   Ni, Yicheng ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^c WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GADODIAMIDE; LIPID; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARATUS; ARTICLE; BLOOD VOLUME; CANCER GROWTH; CANCER MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEASIBILITY STUDY; HISTOLOGY; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LIVER BLOOD FLOW; LIVER TUMOR; MALE; MICROANGIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REPRODUCIBILITY; RHABDOMYOSARCOMA; SIGNAL DETECTION; THREE DIMENSIONAL IMAGING;

ANGIOGRAPHY; ANIMALS; DISEASE MODELS, ANIMAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM TRANSPLANTATION; RATS; RHABDOMYOSARCOMA;

EID: 33646160452     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2392050277     Document Type: Article

References (31)

1. Saini S, Stark DD, Brady TJ, Wittenberg J, Ferrucci JT Jr. Dynamic spin-echo MRI of liver cancer using gadolinium-DTPA: animal investigation. AJR Am J Roentgenol 1986;147:357-362.
2. Yang JH, You TG, Li N, et al. Relationship between the imaging features and pathologic alteration in hepatoma of rats. World J Gastroenterol 2003;9:69-72.
3. Chen MC, Tsang YM, Stark DD, et al. Hepatic metastases: rat models for imaging research. Magn Reson Imaging 1989;7:1-8.
4. Li X, Zheng CS, Feng GS, Zhuo CK, Zhao JG, Liu X. An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features. World J Gastroenterol 2002;8:1035-1039.
5. Qin Y, Van Cauteren M, Osteaux M, Willems G. Quantitative study of the growth of experimental hepatic tumors in rats by using magnetic resonance imaging. Int J Cancer 1992; 51:665-670.
6. Sostman D, Rockwell S, Smith GJ, et al. Magnetic resonance, pathology and physiology of the BA1112 rhabdomyosarcoma in vivo. Invest. Radiol 1988;23:277-288.
7. Antoine E, Pauwels C, Verrelle P, Lascaux V, Poupon MF. In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent. Br J Cancer 1988;57:469-474.
8. Clement O, Frija G, Chanihon C, et al. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 1991;180:31-36.
9. Landuyt VV, Ahmed B, Nuyts S, et al. In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment. Int J Radiat Oncol Biol Phys 2001;49:443-450.
10. Beauregard DA, Hill SA, Chaplin DJ, Brindle KM. The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability. Cancer Res 2001;61:6811-6815.
11. Hermens AF, Barendsen GW. Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat. Eur J Cancer 1967;3:361-369.
12. Denekamp J. The choice of experimental models in cancer research: the key to ultimate success or failure? NMR Biomed 1992; 5:234-237.
13. Thoeny HC, De Keyzer F, Chen F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 2005; 234:750-704.
14. Yang R, Rescorla FJ, Reilly CR, et al. A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 1992;52:193-198.
15. Ni Y, Marchal G, van Damme B, et al. Magnetic resonance imaging, microangiography, and histology in a rat model of primary liver cancer. Invest. Radiol 1992;27:689-697.
16. Nomura K, Miyagawa S, Harada H, et al. Relationship between doubling time of liver metastases from colorectal carcinoma and residual primary cancer. Dig Surg 1998;15: 21-24.
17. Weisskoff R, Boxerman JL, Sorensen AG, Kulke SM, Campbell TA, Rosen BR. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection (abstr). In: Proceedings of the First/Second Meeting of the Society of Magnetic Resonance. Berkeley, Calif: Society of Magnetic Resonance, 1994; 279.
18. Ostergaard L, Hochberg FH, Rabinov JD, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300-305.
19. Provenzale JM, Wang GH, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002; 178:711-716.
20. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004;232:685-692.
21. Le Biham D, Breton E, Lallemand D, Anbin M, Vignand J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168:497-505.
22. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1990;210:617-623.
23. Ichikawa T, Araki T. Fast magnetic resonance imaging of liver. Eur J Radiol 1999;20: 180-210.
24. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion weighted MH images. Radiology 1999; 212:333-339.
25. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004;183:677-680.
26. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? comparative study between relative and quantitative measurement. Radiology 2002;223:361-370.
27. Zaharchuk G, Yamada M, Sasamata M, Jenkins BG, Moskowitz MA, Rosen BR. Is all perfusion-weighted magnetic resonance imaging for stroke equal? the temporal evolution of multiple hemodynamic parameters after focal ischemia in rats correlated with evidence of infarction. J Cereb Blood Flow Metab 2000;20:1341-1351.
28. Tsui EY, Chan JH, Cheung YK, et al. Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography. Clin Imaging 2000; 24:210-216.
29. Jackson A, Haroon H, Zhu XP, Li KL, Thacker NA, Jayson G. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 2002;15:164-173.
30. Lindskog M, Kogner P, Ponthan F, et al. Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (III MRS). Br J Cancer 2003;88:478-483.
31. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524.